Schedule 13D ownership disclosure

BIOTIME INC

Security class unavailable · CUSIP: 09066L105

Event date: 2014-05-08

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
2.7600%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001140361-14-019955
Form type
SC 13D/A
Filer
Lineage Cell Therapeutics, Inc.
CIK
CIK 876343
Filed
May 09, 2014
Reporting period
May 08, 2014
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub